297
Views
4
CrossRef citations to date
0
Altmetric
Low Dose COC

Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old

, , , , &
Pages 825-829 | Received 14 Mar 2014, Accepted 04 Jun 2014, Published online: 23 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jie Li, Yan Sun, Sien Mo, Shujia Wang & Weiwei Luo. (2021) Effects of oral contraceptive for different responder women before GnRH antagonists: a systematic review and meta-analysis. Gynecological Endocrinology 37:11, pages 977-986.
Read now

Articles from other publishers (3)

Annalisa Racca, Panagiotis Drakopoulos, Ana Raquel Neves & Nikolaos P. Polyzos. (2020) Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology. Drugs 80:10, pages 973-994.
Crossref
Cindy Farquhar, Luk Rombauts, Jan AM Kremer, Anne Lethaby & Reuben Olugbenga Ayeleke. (2017) Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews 2017:8.
Crossref
Safak Olgan & Peter Humaidan. (2017) GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study. Reproductive Biology 17:1, pages 105-110.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.